Hemodynamic, morphometric and autonomic patterns in hypertensive rats - renin- angiotensin system modulation

Clinics

Volumn 65, Issue 1, 2010, Pages 85-92

  Zamo, Fernanda S ^a,b   Lacchini, Silvia ^b   Mostarda, Cristiano ^a,b   Chiavegatto, Silvana ^b   Silva, Ivana C M ^b   Oliveira, Edilamar Menezes ^b   Irigoyen, Maria Claudia ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood pressure variability; Hypertension; LVH; RAS; SHR

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

AGE; ANIMAL; BLOOD PRESSURE; DISEASE MODEL; GENETICS; HEMODYNAMICS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

AGE FACTORS; ANGIOTENSINOGEN; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HEMODYNAMICS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; PEPTIDYL-DIPEPTIDASE A; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RENIN-ANGIOTENSIN SYSTEM;

EID: 77649175101     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010000100013     Document Type: Article

References (36)

1. Diamond JA, Phillips RA. Hypertensive heart disease. Hypertens Res. 2005; 28: 191-202.
2. Agabiti-Rosei E, Muiesan ML. Left ventricular hypertrophy and heart failure in women. J Hypertens Suppl. 2002; 20: S34-8.
3. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008; 21: 500-8.
4. Parati G, Ravogli A, Frattola A, Groppelli A, Ulian L, Santucciu C, et al. Blood pressure variability: clinical implications and effects of antihypertensive treatment. J Hypertens Suppl. 1994; 12: S35-40.
5. Su DF, Miao CY. Reduction of blood pressure variability: a new strategy for the treatment of hypertension. Trends Pharmacol Sci. 2005; 26: 388-90.
6. Tatasciore A, Zimarino M, Renda G, Zurro M, Soccio M, Prontera C, et al. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res. 2008; 31: 2137-46.
7. Xie HH, Shen FM, Zhang XF, Jiang YY, Su DF. Blood pressure variability, baroreflex sensitivity and organ damage in spontaneously hypertensive rats treated with various antihypertensive drugs. Eur J Pharmacol. 2006; 543: 77-82.
8. Su DF. Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies. Curr Opin Cardiol. 2006; 21: 486-91.
9. Freslon JL, Giudicelli JF. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol 1983; 80: 533-43.
10. Oddie CJ, Dilley RJ, Bobik A. Long-term angiotensin II antagonism in spontaneously hypertensive rats: effects on blood pressure and cardiovascular amplifiers. Clin Exp Pharmacol Physiol. 1992; 19: 392-5.
11. Wu JN, Berecek KH. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension. 1993; 22: 139-46.
12. Wright JW, Mizutani S, Harding JW. Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies. Heart Fail Rev. 2008; 13: 367-75.
13. Ushizima MR, Moreira ED, Costa ET, Castiglioni P, Krieger EM, Di Rienzo M, et al. Effects of sinoaortic denervation on blood pressure, pulse interval, sympathetic nerve activity and diaphragmatic electromyogram variability in conscious rats. IEEE Proceedings of Computers in Cardiology. 2001; 485-8.
14. Soares PP, da Nóbrega AC, Ushizima MR, Irigoyen MC. Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. Auton Neurosci. 2004; 113: 24-31.
15. Heart rate variability. Standards of measurement, physiological interpretation,and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996; 17: 354-81.
16. Pagani M, Somers V, Furlan R, Dell'Orto S, Conway J, Baselli G, Cerutti S, Sleight P, Malliani A. Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension. 1988; 12: 600-10.
17. Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979; 11: 447-55.
18. Kohara K, Tabuchi Y, Senanayake P, Brosnihan KB, Ferrario CM. Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures. Peptides. 1991; 12: 1135-41.
19. Araujo MC, Melo RL, Cesari MH, Juliano MA, Juliano L, Carmona AK. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme. Biochemistry. 2000; 39: 8519-25.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248-54.
21. Bibancos T, Jardim DL, Aneas I, Chiavegatto S. Social isolation and expression of serotonergic neurotransmission-related genes in several brain areas of male mice. Genes Brain Behav. 2007; 6: 529-39.
22. Ambar G, Chiavegatto S. Anabolic-androgenic steroid treatment induces behavioral disinhibition and downregulation of serotonin receptor messenger RNA in the prefrontal cortex and amygdala of male mice. Genes Brain Behav. 2009; 8: 161-73.
23. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 18; 3: RESEARCH0034.
24. Wichi RB, De Angelis K, Jones L, Irigoyen MC. A brief review of chronic exercise intervention to prevent autonomic nervous system changes during the aging process. Clinics. 2009; 64: 253-8.
25. Minami N, Imai Y, Munakata M, Sasaki S, Sekino H, Abe K, et al. Reversed circadian rhythm of blood pressure in adult spontaneously hypertensive rats. J Hypertens Suppl. 1988; 6: S70-3.
26. El-Mas MM, Abdel-Rahman AA. Longitudinal studies on the effect of hypertension on circadian hemodynamic and autonomic rhythms in telemetered rats. Life Sci. 2005; 76: 901-15.
27. Mancia, G., Parati, G. Ambulatory blood pressure monitoring and organ damage. Hypertension. 2000; 36: 894-900.
28. Penna GL, Garbero R de F, Neves MF, Oigman W, Bottino DA, Bouskela E. Treatment of essential hypertension does not normalize capillary rarefaction. Clinics. 2008; 63: 613-8.
29. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens. 1993; 11: 1133-7.
30. Li L, Yi-Ming W, Li ZZ, Zhao L, Yu YS, Li DJ, et al. Local RAS and inflammatory factors are involved in cardiovascular hypertrophy in spontaneously hypertensive rats. Pharmacol Res. 2008; 58: 196-201.
31. Stegbauer J, Vonend O, Oberhauser V, Sellin L, Rump LC. Angiotensin II receptor modulation of renal vascular resistance and neurotransmission in young and adult spontaneously hypertensive rats. Kidney Blood Press Res. 2005; 28: 20-6.
32. Silva GJ, Moreira ED, Pereira AC, Mill JG, Krieger EM, Krieger JE. ACE gene dosage modulates pressure-induced cardiac hypertrophy in mice and men. Physiol Genomics. 2006; 27: 237-44.
33. Lacchini S, Heimann AS, Evangelista FS, Cardoso L, Silva GJ, Krieger JE. Cuff-induced vascular intima thickening is influenced by titration of the Ace gene in mice. Physiol Genomics. 2009; 37: 225-30.
34. Dang A, Zheng D, Wang B, Zhang Y, Zhang P, Xu M, et al. The role of the renin-angiotensin and cardiac sympathetic nervous systems in the development of hypertension and left ventricular hypertrophy in spontaneously hypertensive rats. Hypertens Res. 1999; 22: 217-21.
35. Paton JF, Wang S, Polson JW, Kasparov S. Signalling across the blood brain barrier by angiotensin II: novel implications for neurogenic hypertension. J Mol Med. 2008; 86: 705-10.
36. Ganten D, Lang RE, Lehmann E, Unger T. Brain angiotensin: on the way to becoming a well-studied neuropeptide system. Biochem Pharmacol. 1984; 15; 33: 3523-8.